Why the study?
Does metoprolol prevent exercise-induced platelet aggregation in middle-aged men with stable angina?
Does metoprolol prevent exercise-induced platelet aggregation in middle-aged men with stable angina?
Metoprolol prevents exercise-induced platelet aggregation and associated cAMP reductions in patients with stable angina, likely by minimizing hemodynamic disturbances.
Metoprolol may blunt exercise-induced platelet hyperaggregability in stable angina; hypothesis-generating and should not yet change practice.
Moderate exercise increased platelet aggregability of 12 middle-aged men with stable angina pectoris: the mean ADP threshold fell from 4.58 +/- 0.63 to 3.18 +/- 0.41 microM, P less than 0.01. Exercise did not, however, alter platelet aggregability in 12 healthy matched controls. Physical effort approximately doubled the plasma levels of adrenaline and noradrenaline in patients as well as in controls. Under the same conditions the cAMP content of platelets fell in the angina group from 20.86 +/- 1.86 to 17.78 +/- 1.71 pmol 10(-9) platelets, P less than 0.01, while there was no change in control levels. The fall of cAMP could account for the observed increase in platelet aggregability. We speculate that the increased aggregability of platelets in the exercising anginal subjects represents an imbalance between prostacyclin release and haemodynamic changes. The beta 1-selective blocker metoprolol, in usual therapeutic dosages, prevented the observed platelet changes probably by minimizing the haemodynamic disturbances and stimulating release of prostacyclin.
No takes yet. Share an insight, caveat, or question.
WlNTHER et al. (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: